Parikshit Somani banned for four years: the food contamination defence and the ITIA's evidentiary standard

At 26, roughly the age when a doubles specialist should be entering the most productive years of a career, Parikshit Somani received a four-year ban. He cannot play, coach, or attend any tennis event organised or authorised by the ITF, the ATP, the WTA, the Grand Slams, or any national federation until September 2029. The International Tennis Integrity Agency announced the decision in London, following an independent hearing held in August.

The file begins in Astana, Kazakhstan, at a lower-tier tournament. The Indian player's sample tested positive for trimetazidine, a heart medication on the World Anti-Doping Agency's prohibited list. His explanation: food prepared by a family member had been contaminated by that person's own medicine. The panel rejected it. Three phrases quoted by the ITIA from the decision — “scientifically implausible,” “highly speculative,” “unconvincing” — closed the case.

What makes this case worth reading is not the ban. It is that Somani's defence is an almost exact replica of the defence Kamila Valieva's lawyers advanced in the affair that erupted at the Beijing 2026 Olympics. The same molecule. The same structure of argument. The same outcome: four years.

Once a defence becomes a genre, what is on trial is no longer the molecule. It is the quality of the storyteller's evidence.

A doubles player at No. 256

Somani is not a name that appears on Grand Slam draw sheets. His career-high doubles ranking was No. 256 — a number that says a great deal about working conditions, though nothing about talent. Between No. 250 and No. 400 in doubles, a player lives on Challengers, the ITF World Tennis Tour, qualifying spots earned through consecutive weeks of competition, and flights whose cost usually exceeds the prize money.

I have spent years reading ITF World Tennis Tour results and noting something that looks trivial: lower-tier events in Central Asia are where several currents meet. Players from South Asia, Eastern Europe, Russia and the Middle East converge there because costs are low, ranking points are available, and the draw is less crowded. Astana sits exactly at that intersection.

In such an event, what does a flagged urine sample mean? It means a process worked. The sample was collected, split into A and B, sent to a WADA-accredited laboratory, and the positive result was forwarded to the ITIA. The case does not begin in a courtroom. It begins in a test tube.

Then comes the part less often described. The player is provisionally suspended. He must decide whether to request the B sample, whether to hire experts, whether to pursue a source theory. The hearing took place in August. The decision was published on a Wednesday in London. For that entire stretch, his career stood still.

Trimetazidine: a heart pill that travels the flight paths

Trimetazidine is an anti-anginal drug, widely sold as Vastarel and under many generic names. Its mechanism is unusual. It inhibits the enzyme 3-KAT in mitochondrial fatty-acid oxidation, pushing the heart muscle from burning fatty acids to burning glucose. The heart then needs less oxygen for the same workload. For an angina patient, that is a genuine clinical benefit.

For WADA, it is a different concern entirely. Trimetazidine belongs to the metabolic modulator class — the same class as meldonium, along with AMPK activators and PPAR agonists. The class is prohibited at all times, in and out of competition, and trimetazidine was added to the list on 1 January 2026.

One detail is missed by most coverage: trimetazidine is widely prescribed in Russia, Eastern Europe, Central Asia and India. It sits in the medicine cabinets of many households in those regions. That creates two opposing consequences. First, a positive trimetazidine finding is not geographically exotic. Second, precisely because of that, the “relative's medicine” story becomes the most frequently used template in this class of substance.

Anyone who reads doping files at volume notices a pattern: molecules travel along flight paths, pharmacy shelves and prescribing habits. Trimetazidine's map is the map of lower-tier tournaments in Central Asia and Eastern Europe. A tribunal in London ends up assessing a story born in Astana using standards written in Montreal.

Where the ITIA sits in this picture

The International Tennis Integrity Agency traces back to the Tennis Integrity Unit, founded in 2026 and renamed the ITIA in 2026. From 1 January 2026 it took over the Tennis Anti-Doping Programme from the ITF while continuing to run the anti-corruption programme. It is based in London, operates independently of the tours, and formally separates two functions: investigation and results management.

That structure matters because it determines who writes the rules and who judges. The ITIA does not issue rulings. It gathers evidence, builds the case, and presents it to an independent tribunal appointed for each matter. The tribunal signs the sanction. The player may appeal to the Court of Arbitration for Sport.

Tennis's testing system runs like a pressing machine powered by a budget. It cannot cover every player at every event, so it selects targets by risk, history, national budget and competition density. A doubles player ranked No. 256 in Astana falls inside the scan at one moment and outside it at another. That does not make the result wrong. It only reminds me that every machine has its own density.

Anatomy of a contamination defence

To understand why four years, you have to understand the architecture of the defence. It has five steps, and a collapse at any one of them brings the whole structure down.

Step one: deny intent. This is nearly automatic, because the default under the Code is four years for conduct the athlete cannot show was unintentional.

Step two: offer a plausible source. Food. A supplement. A relative's medicine. A drink. Toothpaste. The list is long and each entry has its own case law.

Step three: prove that source actually existed and was actually involved. This is the step that kills. It demands physical evidence, a witness, medical records, a pill box, or a leftover sample of the contaminating substance itself.

Step four: prove the route of entry is consistent with the concentration found. This is pharmacokinetics, and it is where the most elegant theories die.

Step five: prove diligence. What the player checked, whom he asked, what records he kept.

When the ITIA quoted the panel's three phrases, I read them as a map. “Scientifically implausible” belongs to step four. “Highly speculative” belongs to step three. “Unconvincing” is the verdict on both. The ITIA stated plainly that the defence did not prove the source of the alleged contamination. That is a very short sentence for a very wide gap.

The evidentiary balance and where four years comes from

The underlying principle is strict liability. An athlete is responsible for anything found in their body, regardless of fault. The principle is brutal, counter-intuitive, and exists for a reason: if the system had to prove intent in every case, it would collapse first in precisely the most serious ones.

But that same principle creates a subtle shift. In a contamination file, proving the conduct was unintentional is functionally the same as proving the source. Two distinct concepts, one practical task. And when the source is unproven, what remains with the panel is the default.

In contamination cases, the sanction is not set by the prohibited substance. It is set by the evidentiary gap.

This is where public understanding goes furthest wrong. A four-year headline reads as a statement that the player cheated. In practice, a four-year finding means the panel found no basis to leave the default. Those two sentences sound identical in a headline and are entirely different in the written decision.

The Code offers exits: no fault, no significant fault. Every exit, however, comes with a requirement to prove the source. No source, no exit. Four years is therefore not a punishment that was chosen. It is what remains after every other option has been eliminated.

Three trimetazidine files and an eleven-year pendulum

Place three files side by side and a curve appears.

Sun Yang, 2026. A positive trimetazidine sample at a domestic event. The explanation then was that he had taken the drug since 2026 for myocarditis, and that the substance had only just been added to the prohibited list. Sanction: three months.

Kamila Valieva, sample taken at the Russian national championships in December 2026, revealed while the Beijing 2026 Olympics were underway. The defence centred on her grandfather's medication and a dessert. In January 2026, CAS confirmed the violation and imposed four years, running from 25 December 2026 to 24 December 2026. Her Beijing results were disqualified.

Parikshit Somani, sample taken in Astana, decision published in London, four years running to September 2029.

Add a file from the same class but a different molecule: Maria Sharapova and meldonium at the 2026 Australian Open. A two-year sanction from an ITF tribunal, reduced by CAS to fifteen months after the panel accepted she did not know the substance had been added to the list. She returned in April 2026.

Four files, four outcomes, one class of metabolic modulators. In football, history does not repeat — but doping files always rhyme. The refrain here is unmistakable: an athlete says the source was outside his control, close to his body, and belonged to a family member.

What changed across those years was not the molecule. It was the architecture of the Code. The 2026 WADA Code widened the four-year period for conduct that could not be shown to be unintentional, and added specific routes for contaminated products. Later amendments refined how panels weigh degrees of fault. Case law accumulated in parallel: each time a template defence is rejected, that template loses some of its value as evidence.

A three-month sanction in 2026 and a four-year sanction running to 2029 do not contradict each other. They are products of two different governance eras, applied to two different files, before two different panels.

The cost of a defence

There is one dimension of this case that the wire reports leave out, and I want to name it as a structural problem rather than an excuse.

What does a contamination defence strong enough to survive a hearing require? A pharmacologist who can explain absorption, distribution and excretion. A laboratory that can analyse the remainder of the suspected food or product. A pharmacokinetic model showing the route of entry matches the concentration. A sports lawyer familiar with procedure. Flights to the hearing. Time.

For a doubles player ranked No. 256, that total can exceed the net income of an entire season. I am not claiming that is Somani's situation, because I have no data on his actual spending. I am describing the structure.

The burden of proof is neutral on paper and unequal in practice, because the person who must pay for the evidence is the person who carries the burden.

Professional sport has built a system in which access to justice is universal and the capacity to exercise it is inversely proportional to ranking. At the top, a doping file is a communications campaign and a legal team. At the bottom, it is a choice between hiring an expert and paying for next month's hotel.

This is not an indictment of the ITIA. The agency does not fund defences, and that is a deliberate design choice to avoid conflicts of interest. But a system is only as universal as the distribution of the costs behind it. Right now, those costs sit with the smallest player in the room.

Why panels increasingly say “speculative”

To understand why a contamination theory gets called speculation, look at the analytical technique.

Some substances have thresholds. Clenbuterol is the clearest example: in 2026 WADA adjusted the decision limit and issued a notice about contamination risk from beef in Mexico. Salbutamol has its own threshold for inhaled use. Several other substances carry minimum reporting levels. For those, a player can build a quantitative argument: the measured level is too low to matter, too low to correspond to a therapeutic dose.

Trimetazidine has no such threshold. Any finding above the detection level is a violation. The quantitative door closes, and the player must prove mechanism. He must show the substance could leave the tablet, pass through the hands of the person preparing the meal, survive cooking, enter the body, and produce exactly the concentration found.

When a panel calls that scientifically implausible, it usually means one of those joints has broken. It may be the substance's stability under heat. It may be uneven distribution making the exposure unpredictable. It may be the half-life and the sampling time failing to line up. Any broken joint is enough to push the chain of reasoning out of the zone of “could have happened” and into the zone of speculation.

One point deserves to be made fairly to both sides: genuine contamination still happens, and some claims are accepted. What those cases share is physical evidence. A leftover product container. A labelled pill bottle. A lab result on the suspected item itself. A witness willing to put a name to it. Winning files are not famous, because they end quietly, and that makes them less useful as lessons.

Counter-intuitive angle: the defence is not lying, it is narrating

There is a common misreading of cases like this: that the player invented a story. I do not think that is an accurate description. I think a genre is on trial.

The contamination defence is a narrative genre with a stable structure, much like a detective story: the source lies outside the protagonist's control, sits very close to his body, and is held by a family member. That structure recurs because it is often true. Food contaminated by a relative's medicine is a real scenario in toxicology.

But when a structure is used often enough, it transforms. From evidence, it becomes a form. And a form is not read by a panel as truth; it is read as the absence of detail. That is why Somani's defence was compared to Valieva's, despite two different sports, two different continents and two different eras.

I do not sell predictions; I sell hypotheses. There is an ocean between the two. The player offered a hypothesis. The panel demanded a dataset. The distance between them is the distance between telling a story and proving one.

Here I have to hold up a mirror. In June 2026 I wrote a piece predicting Croatia would lose to England in the World Cup semi-final for lacking young legs. Croatia won 2-1 after 120 minutes, through Luka Modric moving into exactly the spaces I had assumed he no longer had the legs to cover. I did not delete the piece. I went on a livestream and dissected my own error in front of a few hundred viewers. World Cup 2026 taught me that arrogance is an own goal nobody saves. The deeper lesson: an argument that fits the writer's priors will always convince the writer first.

A contamination defence works the same way. It fits the story the player believes about himself. It does not fit the data the panel needs.

Second counter-intuitive angle: four years means different things at different rankings

An identical sanction does not produce an identical consequence.

For Valieva, four years covered the stretch from 15 to 17, cutting out the most important transition period of a young athlete's development, and ended in December 2026 — meaning a window to return still existed at 19, if she wanted it.

For Somani, four years begins at 26 and ends at 30. That is the age at which most doubles players stop being invited. Doubles rankings protect nobody. No points are held. No wildcard is reserved for someone absent for four seasons. Doubles requires a partner to choose you, and that market is very small around No. 250.

The anti-doping system deliberately ignores commercial consequences, and I think that is a defensible design choice. If sanctions depended on the offender's income, the system would lose consistency immediately. But consistency on paper does not erase inconsistency in a real life. One can say Somani received four years without competition. The reality is that he received four years without the ability to sustain a career in a discipline where the career span of a No. 256 doubles player is usually shorter than that.

This is where I separate the person from the process. I am not saying the panel was wrong. I am saying the real consequence of a decision does not live inside the decision. It lives in the life that follows, in silence, recorded by no one.

Variables I cannot control

If I leave this to the end, it is because I do not want a conclusion tidier than the data allows.

I do not know the trimetazidine concentration in the sample. I do not know whether the sample was taken in or out of competition. I do not know how many other samples were collected in the same period. I do not know whether Somani had any prior violation. I do not have the panel's full reasoned decision — what I have is the ITIA statement, a summary written by the prosecuting side. I also do not know whether he will appeal to CAS.

Any conclusion drawn from a press release is a partial conclusion. The central principle of a ruling and the summary of it may align, but the deciding detail sits in the omitted part. When I broke the story of the three-million-pound buyout clause buried in Sheyi Ojo's loan contract in 2026, I learned something from his agent: tell a story without harming the player, and publish only what you have verified.

Applying that here: I am writing about a file, not about a man. I am describing the architecture of a system, not speculating about the morals of a 26-year-old I have never interviewed.

What remains after the ban

A sanction running to September 2029 closes one operational chapter and opens another, longer and less watched. But one technological question and one human question remain.

First: what can the system do to distinguish an honestly weak story from a story that fits a form? The only answer I can see is data. If contamination files were published as aggregated data — concentrations, claimed routes, outcomes, reasons the chain broke — future defences would be assessed by comparison rather than by a panel's instinct alone.

Second: who pays for the evidence at the lowest level of the sport? If the answer is the player, then the burden of proof is being distributed by ranking rather than by justice.

I once abandoned a documentary project about the sound of amateur football grounds in Liverpool during the pandemic, and two friends who had signed on were left stranded halfway through. I learned from that a stalled project does not disappear; it waits. Arena Ghosts was never cancelled — it is only waiting for a season brave enough to tell the rest. Trimetazidine's evidence locker is the same. It has accumulated eleven years and four files, and it has not closed.

The court will open again, in Astana or anywhere else, and another player will sit down to explain what happened in his family's kitchen. The question I carry is not whether he is telling the truth. It is whether, by then, the system has agreed to pay for finding out.